Daniel M. Hartung

Oregon State University — United States

Medicine · Health Sciences

33h-index4.0kcitations218works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Opioid Use Disorder Treatment(65), Health Systems, Economic Evaluations, Quality of Life(34), Pain Management and Opioid Use(30), Pharmaceutical Practices and Patient Outcomes(24), Mechanical Behavior of Composites(18)

Publications218 total

Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021
Neurology Clinical Practice·2026Open Access
Impact of prescription drug monitoring program integration in the electronic health record on high-risk opioid prescribing in primary care
Pain Medicine·2025
Pharmacy-related syringe access barriers: an audit of Oregon community pharmacies
Harm Reduction Journal·2025Open Access
Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program
Neurology Clinical Practice·2025· 2 citedOpen Access
Adverse outcomes following new benzodiazepine and Z-drug prescriptions among adult Oregon Medicaid beneficiaries: 2016 - 2019
OHSU Digital Commons·2025Open Access
Multiple sclerosis disease-modifying therapy use in the department of veteran affairs and Medicare: A comparative analysis
Multiple Sclerosis and Related Disorders·2024· 1 cited
Chronic Opioid Use After Implementation of Oregon's Medicaid Back Pain Policy
American Journal of Preventive Medicine·2024Open Access
PHARMACIST PROVISION OF HORMONAL CONTRACEPTION IN THE OREGON MEDICAID POPULATION DURING THE COVID-19 PANDEMIC
Contraception·2024
Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmacies
Drug and Alcohol Dependence Reports·2024· 4 citedOpen Access
Trends in Buprenorphine Prescribing in a National Network of Community Health Centers
Drug and Alcohol Dependence·2024
Outcomes After a Statewide Policy to Improve Evidence-Based Treatment of Back Pain Among Medicaid Enrollees in Oregon
Journal of General Internal Medicine·2024· 2 citedOpen Access
Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews
Drug and Alcohol Dependence Reports·2024· 3 citedOpen Access
Budget Impact Analysis of Biosimilar Natalizumab in the US
The American Journal of Managed Care·2024· 3 cited
Changes in Buprenorphine Prescribing in Community Health Centers
JAMA Health Forum·2024· 1 citedOpen Access
Comparison of Multiple Sclerosis Disease-modifying Therapy Utilization Between the Department of Veterans Affairs and US Medicare Health Care Systems (P11-6.004)
Neurology·2024
Effect of integration of prescription drug monitoring program data in the electronic health record on queries by primary care providers
Health Informatics Journal·2024· 4 citedOpen Access
“I go out of my way to give them an extra smile now:” A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials
Research in Social and Administrative Pharmacy·2024· 14 citedOpen Access
Analgesic methadone prescribing in community health centers among patients with chronic pain
Journal of Opioid Management·2023· 1 citedOpen Access
Economic burden of multiple sclerosis in the United States: A systematic literature review
Journal of Managed Care & Specialty Pharmacy·2023· 18 citedOpen Access
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains
Journal of the American Pharmacists Association·2023· 4 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Luke Middleton(7), Kirbee Johnston(6), Dean G. Haxby(6), Sharia M. Ahmed(5), Dennis Bourdette(4), Christoph Busch(4), Hyunjee Kim(4), K. John McConnell(4), Elaine H. Morrato(3), Benjamin G. Druss(3), Robert J. Valuck(3), Elizabeth J. Campagna(3), John W. Newcomer(3), Roger Chou(3), Adriane N. Irwin(3), Jonah Geddes(3), Daniel R. Touchette(3), P. Todd Korthuis(3), Thuan Nguyen(3), Richard A. Deyo(3)